Franck Durif

Trials

Studies that name Franck Durif as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:02 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT02934919 · Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study

  University Hospital, Clermont-Ferrand · unknown · Impulse Control Disorders, Parkinson Disease · principal investigator
• N/A
  NCT02893449 · Psychiatry Study: Parkinson Disease

  Central Hospital, Nancy, France · completed · Parkinson's Disease · principal investigator
• N/A
  NCT02824341 · Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder

  University Hospital, Clermont-Ferrand · completed · Parkinson's Disease, REM Sleep Behavior Disorder · principal investigator
• N/A
  NCT02796040 · Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography.

  University Hospital, Clermont-Ferrand · unknown · Parkinson's Disease, Impulse Control Disorders · principal investigator
• Ph3
  NCT02555982 · Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor

  University Hospital, Clermont-Ferrand · completed · Essential Head Tremor · principal investigator
• N/A
  NCT01794195 · Role of Mesocorticolimbic Pathway in Apathy of Patients With Parkinson's Disease. - Study Using Diffusion Tensor Imaging and Fibres Tracking

  University Hospital, Clermont-Ferrand · completed · Parkinson's Disease, Apathy · principal investigator
• N/A
  NCT01114321 · Glucose Tolerance in Patients With an Idiopathic Parkinson's Disease

  University Hospital, Clermont-Ferrand · completed · Parkinson's Disease · principal investigator
• N/A
  NCT01044992 · Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study

  University Hospital, Toulouse · completed · Multisystemic Atrophy · principal investigator
• Ph3
  NCT00909883 · Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles)

  University Hospital, Clermont-Ferrand · completed · Parkinson's Disease, Foot Dystonia · principal investigator
• N/A
  NCT00663312 · Impact of Deep Brain Stimulation of Subthalamic Nucleus on the Hepatic Glucose Production in Parkinson's Disease

  University Hospital, Clermont-Ferrand · terminated · Idiopathic Parkinson's Disease · principal investigator
• N/A
  NCT00664157 · Facial Expression Recognition of Emotion and Categorization of Emotional Words in Parkinson's Disease. Impact of L-Dopa and Deep Brain Stimulation of Subthalamic Nucleus

  University Hospital, Clermont-Ferrand · completed · Idiopathic Parkinson's Disease · principal investigator
• Ph2
  NCT00529724 · Body Weight Gain, Parkinson, Subthalamic Stimulation

  University Hospital, Clermont-Ferrand · completed · Parkinson's Disease · principal investigator
• Ph1
  NCT00505323 · Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Palliadal Lesion : Evaluation of Safety and Effectiveness

  University Hospital, Clermont-Ferrand · completed · Focal Dystonia · principal investigator
• Ph3
  NCT00276185 · HEMITOX : Effect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After Stroke

  University Hospital, Clermont-Ferrand · unknown · Hemiplegia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.